{"id":546698,"date":"2021-06-08T22:26:02","date_gmt":"2021-06-08T22:26:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=546698"},"modified":"2021-06-08T22:26:02","modified_gmt":"2021-06-08T22:26:02","slug":"covid19-pipeline-emerging-therapies-and-key-pharma-players-involved-by-delveinsight-abbvie-novartis-tonix-pharmaceuticals-molecular-partners-veru-inc-and-many-others","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/covid19-pipeline-emerging-therapies-and-key-pharma-players-involved-by-delveinsight-abbvie-novartis-tonix-pharmaceuticals-molecular-partners-veru-inc-and-many-others_546698.html","title":{"rendered":"COVID-19 Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | AbbVie, Novartis, Tonix Pharmaceuticals, Molecular Partners, Veru Inc. and Many Others"},"content":{"rendered":"
\"COVID-19<\/a><\/p>\n
\n
COVID-19 Pipeline<\/div>\n<\/div>\n<\/div>\n

Coronavirus disease (COVID-19)<\/strong> is an infectious disease caused by the most recently discovered corona virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease causes respiratory illness (like the flu) with symptoms such as a cough, fever, and difficulty breathing. Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Elderly people and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness. The COVID-19 virus is primarily transmitted through droplets of saliva or discharge from the nose when an infected person coughs or sneezes. People can catch COVID-19 if they breathe in droplets from a person with COVID-19 who coughs out or exhales droplets. It also spreads when a person touches a surface or objects that has the virus on it, and then touches their eyes, nose, or mouth.<\/p>\n

DelveInsight’s, “COVID-19 Pipeline<\/a><\/strong> Insight, 2021<\/strong>” report provides comprehensive insights about 150+ companies and 200+ pipeline drugs in COVID-19 pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.<\/p>\n

 <\/p>\n

Request for Free Sample Report: https:\/\/www.delveinsight.com\/sample-request\/covid-19-coronavirus-pipeline-insights<\/a><\/strong><\/p>\n

 <\/p>\n

Some of the COVID-19 Companies are:<\/strong><\/p>\n